Fundraising FoxCareDx
NASDAQ: CDNABrisbane, US · Delaware corporation
Find your way into CareDx
Sign up to see every warm intro you have to CareDx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CareDx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
Founders & leadership
JY
James YeeExecutive
AK
Anders KarlssonExecutiveAnders Karlsson held senior leadership roles in pharma, biotech, and medtech, including CEO of Allenex AB (listed on NASDAQ Stockholm) and Managing Director/Country Head for Novartis Norway. He is an executive officer at CareDx, managing international operations for the transplant diagnostics company.
PM
Peter MaagExecutiveHe has background in pharmaceuticals and diagnostics across multiple geographies, with experience in general management, commercial operations, and product innovation.
CC
Charles ConstantiExecutiveCharles Constanti served as CFO at multiple technology companies including Swimlane, BlastWave, CareDx, Procera Networks, and Netopia, managing finance, accounting, and operations teams across public and private organizations. He began his career as an auditor at PwC and has led financial planning, capital raising, and operational scaling at venture-backed and public companies in SaaS and networking sectors.
MN
Mitchell NellesExecutive
MM
Matthew MyerExecutive
JW
John W. HannaPresident and Chief Executive OfficerJohn W. Hanna is President and Chief Executive Officer of CareDx, which develops diagnostic tools and solutions for transplant patients across the pre- and post-transplant continuum. He has led organizations through mergers, turnarounds, and market expansions, with experience in corporate development, product commercialization, and strategic planning.
KK
Keith KennedyChief Operating Officer and Chief Financial OfficerHe brings over 20 years of executive experience across public accounting, banking, and private equity, including prior roles as Chief Financial Officer and Chief Operating Officer of Veracyte from 2016 to 2021 and Chief Executive Officer of MCG Capital Corporation, alongside positions at GE Capital and Ernst & Young. He holds a B.S. in accounting from Indiana University and an M.B.A. from the College of William & Mary, and is a Chartered Financial Analyst and Certified Public Accountant.
JM
Jessica MengChief Commercial OfficerShe previously held commercial leadership roles at Veracyte, Genentech, Myovant Sciences, and DELFI Diagnostics, with expertise spanning oncology, immunology, and molecular diagnostics.
Board
MG
Michael GoldbergBoard director
Reported raises · per SEC filings
Form D private placements$22.2M disclosed across 1 round · 2016
▶$22.2MraisedJun 2016 · 42 investors · BiotechnologyRule 506(b)
▶$22.2MraisedJun 2016 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William HagstromDirector
- Ralph SnydermanDirector
- James YeeExecutive Officer
- Anders KarlssonExecutive Officer
- Todd WhitsonExecutive Officer
- Michael GoldbergDirector
- Peter MaagExecutive Officer, Director
- John SninskyExecutive Officer
- George BickerstaffDirector
- Charles ConstantiExecutive Officer
- Mitchell NellesExecutive Officer
- Matthew MyerExecutive Officer
- Fred CohenDirector
- Offering amount
- $36.8M
- Amount sold
- $22.2M
- Sales commissions
- $1.1M
- Finders' fees
- $11.7K
- Placement agents
- M.M. Dillon & Co. Group, CIM Securities, LLC, Leerink Partners LLC
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
KidneyThe National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.
UPMCUPMC is a regional healthcare provider that invests in community health through charity care, free and subsidized health programs, and support for seniors, veterans, and food-insecure populations.
Companies working in the same space as CareDx.
In the news
Frequently asked questions
- What does CareDx do?
- CareDx provides innovative solutions and diagnostic tools for transplant patients throughout their pre- and post-transplant journey to improve outcomes and equity in organ transplantation.
- How much funding has CareDx raised?
- CareDx has disclosed $22.2M raised across 1 round.
- Where is CareDx headquartered?
- CareDx is headquartered in Brisbane, US.